129 related articles for article (PubMed ID: 13678655)
1. Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years.
Hong HL; Ton TV; Devereux TR; Moomaw C; Clayton N; Chan P; Dunnick JK; Sills RC
Toxicol Appl Pharmacol; 2003 Sep; 191(3):227-34. PubMed ID: 13678655
[TBL] [Abstract][Full Text] [Related]
2. Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years.
Hong HH; Devereux TR; Melnick RL; Moomaw CR; Boorman GA; Sills RC
Toxicol Pathol; 2000; 28(4):529-34. PubMed ID: 10930038
[TBL] [Abstract][Full Text] [Related]
3. o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis.
Sills RC; Hong HL; Flake G; Moomaw C; Clayton N; Boorman GA; Dunnick J; Devereux TR
Carcinogenesis; 2004 Apr; 25(4):605-12. PubMed ID: 14688030
[TBL] [Abstract][Full Text] [Related]
4. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
Takahara M; Kishibe K; Bandoh N; Nonaka S; Harabuchi Y
Hum Pathol; 2004 Jan; 35(1):86-95. PubMed ID: 14745729
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912
[TBL] [Abstract][Full Text] [Related]
6. Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2003 May; (508):1-280. PubMed ID: 12844193
[TBL] [Abstract][Full Text] [Related]
7. p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.
Duddy SK; Parker RF; Bleavins MR; Gough AW; Rowse PE; Gorospe S; Dethloff LA; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Apr; 156(2):106-12. PubMed ID: 10198275
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in the Catnb gene but not the H-ras gene in hepatocellular neoplasms and hepatoblastomas of B6C3F(1) mice following exposure to diethanolamine for 2 years.
Hayashi SM; Ton TV; Hong HH; Irwin RD; Haseman JK; Devereux TR; Sills RC
Chem Biol Interact; 2003 Dec; 146(3):251-61. PubMed ID: 14642737
[TBL] [Abstract][Full Text] [Related]
9. Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.
Nakatsuka S; Hongyo T; Syaifudin M; Nomura T; Shingu N; Aozasa K
Jpn J Cancer Res; 2002 Mar; 93(3):267-74. PubMed ID: 11927008
[TBL] [Abstract][Full Text] [Related]
10. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
Zhuang SM; Wiseman RW; Söderkvist P
Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
[TBL] [Abstract][Full Text] [Related]
12. Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice [Cancer Lett. 193 (2003) 119-125.
Chou MW; Yan J; Nichols J; Xia Q; Beland FA; Chan PC; Fu PP
Cancer Lett; 2004 Apr; 207(1):119-25. PubMed ID: 15127726
[TBL] [Abstract][Full Text] [Related]
13. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
[TBL] [Abstract][Full Text] [Related]
14. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
[TBL] [Abstract][Full Text] [Related]
16. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
Abraham SC; Klimstra DS; Wilentz RE; Yeo CJ; Conlon K; Brennan M; Cameron JL; Wu TT; Hruban RH
Am J Pathol; 2002 Apr; 160(4):1361-9. PubMed ID: 11943721
[TBL] [Abstract][Full Text] [Related]
17. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months.
Sills RC; Hong HL; Greenwell A; Herbert RA; Boorman GA; Devereux TR
Carcinogenesis; 1995 Jul; 16(7):1623-8. PubMed ID: 7614698
[TBL] [Abstract][Full Text] [Related]
19. beta-Catenin mutation is selected during malignant transformation in colon carcinogenesis.
Yamada Y; Oyama T; Hirose Y; Hara A; Sugie S; Yoshida K; Yoshimi N; Mori H
Carcinogenesis; 2003 Jan; 24(1):91-7. PubMed ID: 12538353
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenic potential of o-nitrotoluene and p-nitrotoluene.
Dunnick JK; Burka LT; Mahler J; Sills R
Toxicology; 2003 Feb; 183(1-3):221-34. PubMed ID: 12504353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]